Epic Research Update : Suven Life Sciences

The promoters holding in the company stood at 64.76% while Institutions and Non-Institutions held 1.42% and 33.82% respectively. Suven Life Sciences has been selected as one of the ‘Best Under A Billion’ companies by Forbes Asia 2014. Forbes Asia’s ‘Best Under A Billion’ list highlights 200 of the best small and midsized listed companies in Asia Pacific with annual revenue under $1 billion. To qualify for the selection, companies must have revenue between $5 million and $1 billion, positive net income and be publicly traded for at least a year.



Real Time News & Trading Trends Keep Liking#EpicResearch



Facebook – Twitter – YouTube – Pinterest –Linkedin –Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips